BSAM
IBB icon

Blue Square Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Blue Square Asset Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-20,150
Closed -$2.66M – 68
2024
Q4 		$2.66M Buy
20,150
+248
+1% +$34.9K 1.33% 27
2024
Q3 		$2.9M Buy
19,902
+580
+3% +$83.9K 1.56% 19
2024
Q2 		$2.65M Buy
19,322
+3,284
+20% +$438K 1.55% 19
2024
Q1 		$2.2M Buy
+16,038
New +$2.19M 1.46% 21

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return

Blue Square Asset Management's IBB Position: Q1 2025 in Review

Blue Square Asset Management sold out of iShares Biotechnology ETF (IBB) in Q1 2025, closing a stake of 20,150 shares — an estimated $2.66M sold.

Blue Square Asset Management first reported a position in IBB in Q1 2024 and held it in 4 quarters. The position peaked at $2.9M in Q3 2024. 832 funds tracked by Wall St. Rank hold IBB as of Q1 2025.

  • Blue Square Asset Management reported no remaining iShares Biotechnology ETF position as of Q1 2025 after selling out during the quarter.
  • Blue Square Asset Management sold 20,150 iShares Biotechnology ETF shares in Q1 2025, an estimated $2.66M.
  • Blue Square Asset Management first reported a position in iShares Biotechnology ETF in Q1 2024 and held it in 4 quarters.
  • Blue Square Asset Management's iShares Biotechnology ETF position peaked at $2.9M in Q3 2024.
  • 832 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2025.

Based on Blue Square Asset Management's 13F filing for Q1 2025, filed 1 May 2025.